InvestorsHub Logo
Followers 23
Posts 1674
Boards Moderated 0
Alias Born 06/03/2013

Re: None

Tuesday, 09/26/2017 10:04:51 PM

Tuesday, September 26, 2017 10:04:51 PM

Post# of 33246
Ref: BMOC91324

Post # 19007

What I am reading at PR is the additional pre-clinical studies.

"The Company is currently preparing to conduct additional pre-clinical studies using its newly developed electroceutical technology in the treatment of critical limb ischemia, kidney disease and Non-Alcoholic Steatohepatitis (NASH).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENDV News